Hostname: page-component-848d4c4894-sjtt6 Total loading time: 0 Render date: 2024-07-07T12:01:55.107Z Has data issue: false hasContentIssue false
  • English
  • Français

Identifying Outliers of Antibiotic Usage in Prevalence Studies on Nosocomial Infections

Published online by Cambridge University Press:  02 January 2015

Petra Gastmeier ,
Dorit Sohr ,
Dietmar Forster ,
Gabriele Schulgen ,
Martin Schumacher ,
Franz Daschner  and
Henning Rüden
Petra Gastmeier*
Affiliation:
Institute of Hygiene, Free University of Berlin, Berlin, Germany
Dorit Sohr
Affiliation:
Institute of Hygiene, Free University of Berlin, Berlin, Germany
Dietmar Forster
Affiliation:
Institute of Environmental Medicine and Hospital Hygiene, Albert Ludwigs University, Freiburg, Germany
Gabriele Schulgen
Affiliation:
Institute of Medical Biometry and Medical Informatics, Albert Ludwigs University, Freiburg, Germany
Martin Schumacher
Affiliation:
Institute of Medical Biometry and Medical Informatics, Albert Ludwigs University, Freiburg, Germany
Franz Daschner
Affiliation:
Institute of Environmental Medicine and Hospital Hygiene, Albert Ludwigs University, Freiburg, Germany
Henning Rüden
Affiliation:
Institute of Hygiene, Free University of Berlin, Berlin, Germany
*
Institute of Hygiene, Free University Berlin, Heubnerweg 6, 14 059 Berlin, Germany
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To investigate whether the correlation between patients' antibiotic treatment (yes/no) and patients' infections (yes/no) in each hospital department, described by Pearson's correlation coefficient (ρ) for binary data as a measure for adequate use of antibiotics, is an appropriate quality indicator.

Design:

Comparison of the results of repeated prevalence studies in different hospitals with the data of a national prevalence study, comparing the hospital (ρ) and reference (ρNIDHP[Nosokomiale Infektionen in Deutschland: Erfassung und Prävention]) correlation coefficients for “use of antibiotics/ presence of infections.”

Setting:

The data of 5,377 surgical patients were separated from the total data of a national prevalence study in 72 representative hospitals to create a reference correlation coefficient (ρNIDEP) with a reference range. Nine additional prevalence studies, involving a total of 4,984 patients, were repeatedly performed in the surgical departments of 8 other hospitals during a 12-month period, whereby the correlation coefficients ρn for every prevalence investigation were determined.

Results:

In the national prevalence study, 15.3% of the surgical patients received antibiotics on the study day. Surgical patients had a 3.8% prevalence of nosocomial infections and a 7.0% prevalence of community-acquired infections. Pearson's correlation coefficient ρNIDEP for correlation between patients' binary data use of antibiotics and presence of infection was 0.62. To compare the correlation coefficient of each department with the appropriate reference range, the coefficients of the single departments were plotted against the number of patients; in these plots, three lines indicated the value ρNIDEP and the upper and lower reference ranges, depending on the number of patients. Seven of eight surgical departments investigated during the repeated prevalence studies were found to be within the reference range, near the reference value, in the majority of prevalence studies; only one of the departments was identified as an outlier as regards antibiotic use.

Conclusion:

The correlation between patients' antibiotic treatment (yes/no) and patients' infections (yes/no) in hospitals or departments, as described by Pearson's correlation coefficient ρ for binary data with a definitive reference range depending on the number of patients, is useful for quality management in identifying the overall necessity for evaluating the indications for antibiotic use in one's own hospital.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 21 , Issue 5 , May 2000 , pp. 324 - 328
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Kortas, K, Segreti, J, Donnely, A, Pierpaoli, P, Tenholme, G, Levin, S. An anti-infective review and monitoring program. Pharm Ther 1993;18:291–296.Google Scholar
2. Kunin, C. The responsibility of the infectious disease community for the optimal use of antimicrobial agents. J Infect Dis 1985;151:388–398.Google Scholar
3. Pestotnik, S, Classen, D, Evans, R, Burke, J. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 1996;124:884–890.CrossRefGoogle ScholarPubMed
4. Gaynes, R. Antibiotic resistance in ICUs: a multifaceted problem requiring a multifaceted solution. Infect Control Hosp Epidemiol 1995;16:328–330.Google Scholar
5. Kresken, M, Hafner, D. Prävalenz der Antibiotikaresistenz bei klinisch wichtigen Infektionserregern in Mitteleuropa. Chemotherapie Journal 1996;5:225–230.Google Scholar
6. Shlaes, DM, Gerding, DN, John, JF, Craig, WA, Bornstein, DL, Duncan, RA, et al. SHEA position paper: Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the prevention of antimicrobial resistance: guidelines for the prevention of antimicrobial resistance in hospital. Infect Control Hosp Epidemiol 1997; 18:275–259.Google Scholar
7. Duncan, RA. Controlling use of antimicrobial agents. Infect Control Hosp Epidemiol 1997;18:260–266.CrossRefGoogle ScholarPubMed
8. Gastmeier, P, Kampf, G, Wischnewski, N, Hauer, T, Schulgen, G, Schumacher, M, Daschner, F, Rüden, H. Prevalence of nosocomial infections in representatively selected German hospitals. J Hosp Infect 1998;38:37–49.Google Scholar
9. Gastmeier, P, Kampf, G, Wischnewski, N, Schumacher, M, Daschner, F, Rüden, H. Importance of the surveillance method—various national prevalence studies on nosocomial infections and limits of comparison. Infect Control Hosp Epidemiol 1998;19:661–667.Google Scholar
10. Garner, JS, Emori, WR, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128–140.Google Scholar
11. Gastmeier R Kampf, G, Hauer, T, Schlingmann, J, Schumacher, M, Daschner, F, et al. Experience with two validation methods in a prevalence survey on nosocomial infections. Infect Control Hosp Epidemiol 1998; 19:668–673.Google Scholar
12. Gardner, MJ, Altaian, DG. Statistics With Confidence. London, England: British Medical Journal Books; 1989:46–49.Google Scholar
13. Airman, DG. Practical Statistics for Medical Research. London, UK: Chapman & Hall; 1991:293–295.Google Scholar
14. Rüden, H, Gastmeier, P, Daschner, F, Schumacher, M. Nosocomial and community-acquired infections in Germany. Summary of the results of the first national prevalence study (NIDEP). Infection 1997;25:199–202.Google Scholar
15. French, G, Philipps, I. Antimicrobial resistance in hospital flora and nosocomial infections. In: Mayhall, CG, ed. Hospital Epidemiology and Infedion Control. Baltimore, MD: Williams & Wilkins; 1997:980–999.Google Scholar
16. Cook, D, Salter A Philipps, I. The impact of antibiotic policy on prescribing in a London teaching hospital. A one-day prevalence survey as an indicator of antibiotic use. J Antimicrob Chemother 1983;11:447–453.Google Scholar
17. EPINE Working Group. Prevalence of hospital-acquired infections in Spain. J Hosp Infect 1992;20:1–13.Google Scholar
18. Mayon-White, R, Ducel, G, Kereselidze, T, Tikomirov, E. An international survey of the prevalence of hospital-acquired infection. J Hosp Infect 1983;11(suppl A):43–48.Google Scholar
19. Jepsen, OB, Mortensen, N. Prevalence of nosocomial infections and infection control in Denmark. J Hosp Infed 1980;1:237–244.Google Scholar
20. Goldman, DA, Weinstein, RA, Wenzel, RP, Tablan, OC, Duma, RU, Gaynes, RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA 1996;275:234–240.Google Scholar
21. Frank, M, Batteiger, B, Sorensen, S, Hartstein, A, Carr, J, McComb, J, et al. Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program. Clinical Performance and Quality Health Care 1997;5:180–188.Google Scholar